Universal Health Services Inc (UHS) Stock Price & Analysis
Universal Health Services Inc (UHS) rose 2.60% to USD 146.59 as of June 9, 2026 at 23:39 UTC, according to Nexqual real-time market data.
UHS last closed at USD 142.87; the session ranged USD 141.74–146.75 on volume of 843,532 shares. Market capitalization is $8.87B, with a 52-week range of USD 140.08–246.33 (NYQ). Source: Nexqual, June 9, 2026 at 23:39 UTC.
Key Statistics (as of June 9, 2026 at 23:39 UTC)
| Price | USD 146.59 |
|---|---|
| Change | ▲ 2.60% (up) |
| Previous Close | USD 142.87 |
| Open | USD 143.27 |
| Day Range | USD 141.74 – 146.75 |
| 52-Week Range | USD 140.08 – 246.33 |
| Volume | 843,532 shares |
| Market Cap | $8.87B |
| Exchange | NYQ |
Technical Analysis (UHS)
Nexqual's technical model rates UHS "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 9, 2026 at 23:39 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 33.87 (neutral) |
| vs SMA50 | Below (USD 168.12) |
| MACD | -7.75 (negative) |
Analyst Ratings (UHS)
Wall Street analysts rate UHS "Buy" based on 17 analysts, with a mean price target of USD 215.76 (range USD 165–310), per Nexqual as of June 9, 2026 at 23:39 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 17 |
| Mean Target | USD 215.76 |
| High Target | USD 310 |
| Low Target | USD 165 |
| Buy / Hold / Sell | 8 / 11 / 1 |
Earnings (UHS)
| Next Earnings Date | 2026-07-27 |
|---|---|
| EPS Estimate | USD 5.89 |
| Revenue Estimate | $4.57B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 5.62 vs est 5.46 ▲ beat |
| 2025-12-31 | USD 5.88 vs est 5.91 ▼ miss |
| 2025-09-30 | USD 5.69 vs est 4.95 ▲ beat |
| 2025-06-30 | USD 5.35 vs est 4.96 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:39 UTC.
Financials & Fundamentals (UHS)
| Total Revenue | $17.76B |
|---|---|
| Revenue Growth (YoY) | +9.60% |
| Gross Margin | +44.23% |
| Operating Margin | +11.19% |
| Profit Margin | +8.56% |
| ROE | +21.37% |
| Debt / Equity | 67.41 |
| Current Ratio | 1.08 |
| Total Cash | $119.03M |
| Total Debt | $5.13B |
| Free Cash Flow | $650.82M |
Source: Nexqual, June 9, 2026 at 23:39 UTC.
Financial Health Score (UHS)
Nexqual rates Universal Health Services Inc's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:39 UTC.
| Growth | Solid — Revenue +10% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 11% |
| Balance Sheet | Solid — $119M cash vs $5.13B debt |
| Cash Flow | Mixed — FCF $651M, slim 3.7% margin |
| Efficiency | Strong — ROE 21%, ROA 8.4% |
Ownership (UHS)
| Insider Ownership | +4.83% |
|---|---|
| Institutional Ownership | +101.57% |
| Shares Outstanding | 53.29M |
| Float | 50.33M |
| Short % of Float | +7.03% |
Source: Nexqual, June 9, 2026 at 23:39 UTC.
Leadership (UHS)
Universal Health Services Inc is led by Marc D. Miller (age 54), CEO, President & Director, per Nexqual as of June 9, 2026 at 23:39 UTC.
| CEO, President & Director | Marc D. Miller (age 54) |
|---|---|
| Founder & Executive Chairman of the Board | Alan B. Miller (age 87) |
| Executive VP, CFO & Secretary | Steve G. Filton (age 67) |
| Executive VP & President of Behavioral Health Care Division | Matthew Jay Peterson (age 55) |
| Executive VP & President of Acute Care Division | Edward H. Sim (age 53) |
Major Backers & Investors (UHS)
Notable institutional backers of Universal Health Services Inc include First Eagle Investment Management, LLC, Invesco, Pzena Investment Management LLC, according to Nexqual as of June 9, 2026 at 23:39 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Eagle Investment Management, LLC | 14.13% |
| Invesco | 4.68% |
| Pzena Investment Management LLC | 3.59% |
| Goldman Sachs | 2.5% |
| Fidelity | 1.33% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 20.48% |
| BlackRock | 9.49% |
| State Street | 6.07% |
| Geode Capital | 3.66% |
| Dimensional Fund Advisors | 3.34% |
Source: Nexqual, June 9, 2026 at 23:39 UTC.
From Universal Health Services Inc's Latest SEC 10-K Filing (filed 2026-02-25)
Key Strengths & Strategy (as disclosed to the SEC)
- United Kingdom data protection laws, including the UK Data Protection Act and legislation commonly referred to as the UK GDPR, has required us to implement, and in the future may require us to implement, additional costly, technical and organizational measures designed to protect the privacy and security of each of our patient's health and related financial information, and other personal information.
- Given the critical nature of this information, we have developed and implemented a robust cybersecurity risk management program to assess, identify, and manage risks associated with cybersecurity threats as identified in Item 106(a) of Regulation S-K.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HCA | HCA Healthcare, Inc. | USD 374.9 | ▲ 0.74% |
| TFX | Teleflex Incorporated | USD 135.75 | ▲ 4.55% |
| COO | The Cooper Companies, Inc. | USD 68.62 | ▲ 1.9% |
| THC | Tenet Healthcare Corporation | USD 166.36 | ▲ 2.65% |
| HSIC | Henry Schein, Inc. | USD 80.03 | ▲ 3.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:39 UTC. This page is informational and not investment advice.